Skip to content

IBC-Research with Hazardous Materials

All research conducted by Texas A&M University-Commerce employees or students, involving any of the agents/materials listed below, must be approved by the Texas A&M University-Commerce Institutional Biosafety Committee (IBC) prior to initiation of the research:

  • Pathogens and potential pathogens of humans, animals or plants;
  • Materials potentially containing human pathogens (including human blood, tissue, and cell lines; non-human primate blood, tissue, and cell lines);
  • Recombinant DNA (and RNA) including creation or use of transgenic plants and animals;
  • Select agents and toxins (see including strains and amounts exempted from the select agent regulations;
  • Any material requiring a Center for Disease Control import license or a United States Department of Agriculture permit.

Biosafety Required Training

Research training is met by successful completion of online training modules from the Collaborative Institutional Training Initiative (CITI) website.  All individuals, principal investigators, co-investigators, post-docs, research assistants, undergraduate and graduate students and all other personnel engaged in research must complete the CITI training modules. The time to complete the training modules may be 4-6 hours. You may exit and resume the training at any time.  Once successfully completed, a refresher course is required every three years.  A notification will be sent to you prior to the expiration of your training.  At any time, you may return to the training modules and print a certificate. CLICK HERE TO REGISTER AND BEGIN YOUR TRAINING.



Biosafety Protocol Forms

To gain approval of your biosafety research you must complete and submit the appropriate biosafety protocol forms.

Required Protocol Forms

Additional Protocol Forms (if applicable)

Please submit your protocols to Ms. Glenda Denton, Office of Sponsored Programs or

All IBC submissions (new protocols, renewals or amendments) MAY require full board review and must be reviewed at convened meetings of the IBC. To ensure adequate time for review and consideration, submissions should be sent to by the deadlines indicated below. Prescreening by the IBC staff may identify revisions required by the investigator. These revisions could delay full board review, so all investigators and others are asked to please plan accordingly and submit early.